Drug Approval | October 30, 2022
Zydus receives final approval from USFDA for Acetaminophen injection
Acetaminophen injection had annual sales of US $72 million in the United States according to IQVIA data
Acetaminophen injection had annual sales of US $72 million in the United States according to IQVIA data
The company's long-term strategy is on science, technology and innovation and the company's strategy relating to this is on track
Gland Pharma Q2 FY2023 consolidated net profit up at Rs. 241.24 Cr
Ketorolac Tromethamine Tablets are indicated to relieve moderately severe pain, usually after surgery.
The global VR market to grow at a compound annual growth rate of 13% from $7 billion in 2018 to $28 billion in 2030.
Pluvicto and Scemblix launches are progressing well and we are awaiting data in earlier lines of therapy.
Micafungin for Injection had annual sales of US $99 million in the United States according to IQVIA data
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 112 million in the U.S. (IQVIA MAT August 2022).
Around 62% of the revenues came from the domestic market and 38% from the exports market for Q2 FY23 for a standalone business
A well researched and affordable fixed dose combination, which will significantly improve the glycemic control in adult patients suffering from uncontrolled Type 2 diabetes, especially the ones with comorbidities
Subscribe To Our Newsletter & Stay Updated
